Search results
5 mar 2024 · Researchers at UCL and UCLH have successfully completed the first trial of a therapy designed to restore hearing loss. The REGAIN trial, the results of which were published in Nature ...
10 lip 2023 · Summary: The findings could benefit efforts to develop new ways to treat and prevent hearing loss, including age-related hearing loss. Share: FULL STORY. University of Virginia School...
19 kwi 2023 · Researchers move closer to gene therapy solution for hearing loss. Hearing loss affects about 48 million Americans and 430 million people worldwide, with those numbers expected to grow as populations age. More than 90 percent of individuals affected have sensorineural hearing loss, caused by damage to the inner ear and the destruction of the ...
21 mar 2024 · Results from the REGAIN trial suggest the drug – which has the technical name gamma secretase inhibitor LY3056480 – did not restore hearing across the group of adults with mild to moderate hearing loss from the UK, Germany and Greece.
5 mar 2024 · The REGAIN trial, the results of which were published in Nature Communications, was the first study of a treatment aimed at restoring lost hearing, focusing on a drug with the technical name gamma secretase inhibitor LY3056480.
11 paź 2023 · A world-first trial of a gene therapy to cure a form of deafness has begun, potentially heralding a revolution in the treatment of hearing loss. Up to 18 children from the UK, Spain and the...
9 kwi 2022 · MIT spinout Frequency Therapeutics’ drug candidate stimulates the growth of hair cells in the inner ear. Frequency Therapeutics, a biotechnology company, is working to repair hearing loss using a novel kind of regenerative treatment rather than hearing aids or implants.
